Proteomic analysis of the bone marrow microenvironment in extramedullary multiple myeloma patients

被引:6
作者
Gregorova, Jana [1 ]
Vychytilova-Faltejskova, Petra [1 ,2 ]
Kramarova, Tereza [1 ]
Knechtova, Zdenka [3 ]
Almasi, Martina [4 ]
Stork, Martin [3 ]
Pour, Ludek [3 ]
Kohoutek, Jiri [5 ]
Sevcikova, Sabina [1 ]
机构
[1] Masaryk Univ, Fac Med, Dept Pathophysiol, Babak Myeloma Grp, Brno, Czech Republic
[2] Masaryk Univ, Ctr Mol Med, Cent European Inst Technol CEITEC, Brno, Czech Republic
[3] Univ Hosp Brno, Dept Internal Med, Hematol & Oncol, Brno, Czech Republic
[4] Univ Hosp Brno, Dept Clin Hematol, Brno, Czech Republic
[5] Masaryk Univ, Fac Sci, Dept Expt Biol, Sect Genet & Mol Biol, Brno, Czech Republic
关键词
multiple myeloma; extramedullary disease; cytokine; bone marrow microenvironment; protein association network analysis; C-REACTIVE PROTEIN; CIRCULATING ADIPONECTIN; NEUROTROPHIC FACTOR; CELLS; EXPRESSION; MIGRATION; RECEPTORS; GROWTH; RISK; CHEMOKINES;
D O I
10.4149/neo_2021_210527N715
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Multiple myeloma (MM) is a heterogeneous hematological malignancy characterized by the uncontrolled clonal proliferation of bone marrow (BM) plasma cells. The poor prognosis of patients is associated with the presence of extramedullary disease (EMD). Previously, different mechanisms involved in the colonization of BM niches by MM cells and their escape during EMD have been described. Thus, we aimed to investigate the expression of selected cytokines in the BM plasma of MM patients as well as EMD patients to reveal novel molecules involved in EMD pathogenesis. Expression of 120 different cytokines was measured in BM plasma of 13 MM and 11 EMD patients using Proteome Profiler Antibody Arrays. The correlation between statistically significant cytokines and clinicopathological parameters of patients was determined using the Spearman correlation analysis. Finally, protein-protein interactions were analyzed, and GO and KEGG pathways enrichment analysis was performed. In total, 27 cytokines were found to be differently expressed between MM and EMD patients. After the Benjamini-Hochberg correction for multiple testing, the statistical significance of two cytokines downregulated in EMD (EGF, BDNF) and six cytokines upregulated in EMD (NAP-2, ADIPOQ, CRP, MIG, BAFF, and THBS1) was maintained. Correlation analysis proved a significant association between the expression of these molecules and selected clinical-pathological features of MM/EMD patients. Protein association network analysis revealed important protein-protein interactions between THBS1/EGF, MIG/NAP-2, THBS1/NAP-2, EGF/NAP-2, and ADIPOQ/CRP. Finally, identified cytokines were proved to be significantly involved in focal adhesion, PI3K/AKT, and MAPK signaling pathways, and regulation of cell development, localization, proliferation, migration, differentiation, immune system processes, and stress response. Obtained results confirm the key function of the BM microenvironment in the pathogenesis of MM and indicate the essential role of numerous cytokines in disease progression and EMD development. However, the exact mechanisms need to be further clarified.
引用
收藏
页码:412 / 424
页数:13
相关论文
共 65 条
  • [1] Gene silencing of the BDNF/TrkB axis in multiple myeloma blocks bone destruction and tumor burden in vitro and in vivo
    Ai, Li-Sha
    Sun, Chun-Yan
    Wang, Ya-Dan
    Zhang, Lu
    Chu, Zhang-Bo
    Qin, You
    Gao, Fei
    Yan, Han
    Guo, Tao
    Chen, Lei
    Yang, Di
    Hu, Yu
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (05) : 1074 - 1084
  • [2] Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma
    Alsayed, Yazan
    Ngo, Hai
    Runnels, Judith
    Leleu, Xavier
    Singha, Ujjal K.
    Pitsillides, Costas M.
    Spencer, Joel A.
    Kimlinger, Teresa
    Ghobrial, Joanna M.
    Jia, Xiaoying
    Lu, Ganwei
    Timm, Michael
    Kumar, Ashok
    Cote, Daniel
    Veilleux, Israel
    Hedin, Karen E.
    Roodman, G. David
    WitZig, Thomas E.
    Kung, Andrew L.
    Hideshima, Teru
    Anderson, Kenneth C.
    Lin, Charles P.
    Ghobrial, Irene M.
    [J]. BLOOD, 2007, 109 (07) : 2708 - 2717
  • [3] BATAILLE R, 1992, BLOOD, V80, P733
  • [4] Distinct Clinical Outcomes between Paramedullary and Extramedullary Lesions in Newly Diagnosed Multiple Myeloma
    Batsukh, Khishigjargal
    Lee, Sung-Eun
    Min, Gi June
    Park, Sung Soo
    Jeon, Young-Woo
    Yoon, Jae-Ho
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Kim, Hee-Je
    Lee, Seok
    Cho, Seok-Goo
    Kim, Dong-Wook
    Lee, Jong Wook
    Min, Woo-Sung
    Min, Chang-Ki
    [J]. IMMUNE NETWORK, 2017, 17 (04) : 250 - 260
  • [5] Different outcomes of the Wilcoxon-Mann-Whitney test from different statistics packages
    Bergmann, R
    Ludbrook, J
    Spooren, WPJM
    [J]. AMERICAN STATISTICIAN, 2000, 54 (01) : 72 - 77
  • [6] Extramedullary multiple myeloma
    Bhutani, Manisha
    Foureau, David M.
    Atrash, Shebli
    Voorhees, Peter M.
    Usmani, Saad Z.
    [J]. LEUKEMIA, 2020, 34 (01) : 1 - 20
  • [7] Bolomsky A, 2014, BLOOD, V124
  • [8] Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1,-2 and-3
    Broek, IV
    Asosingh, K
    Vanderkerken, K
    Straetmans, N
    Van Camp, B
    Van Riet, I
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 (06) : 855 - 862
  • [9] The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients
    Cao, Yanran
    Luetkens, Tim
    Kobold, Sebastian
    Hildebrandt, York
    Gordic, Maja
    Lajmi, Nesrine
    Meyer, Sabrina
    Bartels, Katrin
    Zander, Axel R.
    Bokemeyer, Carsten
    Kroeger, Nicolaus
    Atanackovic, Djordje
    [J]. EXPERIMENTAL HEMATOLOGY, 2010, 38 (10) : 860 - 867
  • [10] Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation
    Chakraborty, R.
    Muchtar, E.
    Kumar, S. K.
    Buadi, F. K.
    Dingli, D.
    Dispenzieri, A.
    Hayman, S. R.
    Hogan, W. J.
    Kapoor, P.
    Lacy, M. Q.
    Leung, N.
    Gertz, M. A.
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 (02) : 155 - 161